|
Aiuti A., Webb I.J., Bleul C, Springer T., and Gutierrez-Ramos J.C.:The chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J.Exp. Med. 185, No1, Jan.1, 111-120,1997 Alexander,C.M., Hansell,E.J., Behrendtsen,O., Flannery,M.L., Kishnani,N.S., Hawkes,S.P., and Werb,Z. (1996). Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development - Supplement 122, 1723-1736. Alho,A.M. and Underhill,C.B. (1989). The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. Journal of Cell Biology 108, 1557- 1565. Aljada A, Ghanim H, Mohanty P, Hofmeyer D, Tripathy D, Dandona P. Hydrocortisone suppresses intranuclear activator-protein-1 (AP-1) binding activity in mononuclear cells and plasma matrix metalloproteinase 2 and 9 (MMP- 2 and MMP-9). J. Clin. Endocrinol. Metab. 2001; 86:5988-91. Baggiolini, M. Chemokines in pathology and medicine. J Intern Med,250:91-104, 2001 Bleul C.C, Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., Spronger T.A.:A highly efficacious lymphocytr chemoattractant, stromal cell- derived factor 1 (SDF-1). J.Exp. Med. 184: 1101-1109, 1996 Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A., and Mackay, C. R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci U S A, 94: 1925-1930, 1997. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res. 1989; 49: 4682-4689. Burger, M., Glodek, A., Hartmann, T., Schmitt-Graff, A., Silberstein, L. E., Fujii, N., Kipps, T. J., and Burger, J. A. Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene, 22: 8093-8101, 2003. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563-572. Conner EA, Teramoto T, Wirth PJ, Kiss A, Garfield S, Thorgeirsson SS. HGF-mediated apoptosis via p53/bax-independent pathway activating JNK1. Carcinogenesis 1999; 20: 583-590. Deryugina, E. I., Bourdon, M. A., Luo, G. X., Reisfeld, R. A., and Strongin, A. Matrix metalloproteinase-2 activation modulates glioma cell migration (1997) J. Cell Sci. 110, 2473-2482 D. Uchida, N.M. Begum, A. Almofti, K. Nakashiro, H. Kawamata, Y. Tateishi, H. Hamakawa, H. Yoshida and M. Sato. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma Exp. Cell Res. 290 (2003), pp. 289–302. Donzella G. A., Schols D., Lin S. W., Este J. A., Nagashima K. A., Maddon P. J., Allaway G. P., Sakmar T. P., Henson G., De Clercq E., Moore J. P. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat. Med., 4: 72-77, 1998. F. Alves, U. Borchers, B. Padge, H. Augustin, K. Nebendahl, G. Kloppel and L.F. Tietze. Inhibitory effect of a matrix metalloproteinase inhibitor on growth and spread of human pancreatic ductal adenocarcinoma evaluated in an orthotopic severe combined immunodeficient (SCID) mouse model . Cancer Lett. 165 (2001), pp. 161–170. Ganju R.K., Brubaker S.A., Meyer J., Dutt P., Yang Y., Qin S., Newman W., Groopman J.E.:The α-chemokine, stromal cell-derived factor-1α, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activated mutiple signal transduction pathways. The J. of Biol. Chem. 273, No6, Sept 4:23169-23175, 1998 Giatromanolaki A. Prognostic role of angiogenesis in non-small cell lung cancer. Anticancer Res. 2001; 21: 4373-4382. Gupta, S. K., Lysko, P. G., Pillarisetti, K., Ohlstein, E., and Stadel, J. M. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem, 273: 4282-4287, 1998. Han Y., He T., Huang D., Pardo C. A., Ransohoff R. M. TNF-a mediates SDF-1a-induced NF-kB activation and cytotoxic effects in primary astrocytes. J. Clin. Investig., 108: 425-435, 2001. Hendrix C. W., Flexner C., MacFarland R. T., Giandomenico C., Fuchs E. J., Redpath E., Bridger G., Henson G. W. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob. Agents Chemother., 44: 1667-1673, 2000. Hesselgesser, J., Halks-Miller, M., DelVecchio, V., Peiper, S. C., Hoxie, J., Kolson, D. L., Taub, D., and Horuk, R. CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr Biol, 7: 112-121, 1997. Inngjerdingen M., Torgersen K.M, Maghazachi A.A.:Lck is required for stromal cell- derived factor 1α (CXCL12)- induced lymphoid cell chemotaxis. Blood, 99, No.12, June 15: 4318-4325, 2002 J.A. Uria, M. Stahle-Backdahl, M. Seiki, A. Fueyo, C. Lopez-Otin, Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions, Cancer Res. 57 (1997) 4882-4888 Janowska-Wieczorek A, Marquez LA, Dobrowsky A, Ratajczak MZ, Cabuhat ML.: Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp Hematol. 2000 Nov;28(11):1274-85. Johnsen M, Lund LR, Romer J, Almholt K, Dano K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr. Opin. Cell. Biol. 1998; 10:667-71. Karin M., Liu Z.-G., Zandi E., AP-1 function and regulation. AP-1 function and regulation . Curr. Opin. Cell Biol., Volume: 9, (1997), pp. 240—246 Kim C.H., Broxymer H.E.:In vitro behavior of haematopoietic progenitor cells under the influence of chemoattractant, stromal cell- derived factor-1, steel factor, and bone marrow environment. Blood 91:100-110, 1998 Kim D, Kim S, Koh H, Yoon SO, Chung AS, Cho KS, Chung J. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J. 2001; 15:1953-62. Komori, H. Yagi, S. Nomua, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R. T. Bronson, Y.H. Gao, M.Inada, M.Sato, R. Okamoto, Y. Kitamura, S. Yoshiki, T. Kishimoto, Targeted disrubtion of Cbfal results in acomplete lack of bone formation owing to maturational arrest of osteoblasts, Cell 89(1997) 755-764 Koshiba, T., Hosotani, R., Miyamoto, Y., Ida, J., Tsuji, S., Nakajima, S., Kawaguchi, M., Kobayashi, H., Doi, R., Hori, T., Fujii, N., and Imamura, M. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res, 6: 3530-3535, 2000. Kubiatowski T, Jang T, Lachyankar MB, Salmonsen R, Nabi RR, Quesenberry PJ, Litofsky NS, Ross AH, Recht LD. Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas. J. Neurosurg. 2001; 95:480-8. Lavi, E., J. M. Strizki, A. M. Ulrich, W. Zhang, L. Fu, Q. Wang, M. O''Connor, J. A. Hoxie, and F. Gonzalez-Scarano. 1997. CXCR-4 (fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am. J. Pathol. 151:1035-1041. Liabakk NB, Talbot I, Smith RA, Wilkinson K, Balkwill F. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 1996; 56:190-6. Libura J, Drukala J, Majka M, Tomescu O, Navenot JM, Kucia M, Marquez L, Peiper SC, Barr FG, Janowska-Wieczorek A, Ratajczak MZ.: CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood. 2002 Oct 1;100(7):2597-606. Madri, J., Graesser, D., and Haas, T. (1996) Biochem. Cell Biol. 74, 749-757 Ma Q., Jones D., Borghesani P.R., and Springer T.:Impaired B-lymphopoiesis , myelopoiesis, and derailed cerebellar neuron migration in CXCR4 and SDF-1- deficient mice. Proc. Natl. Acad Sci. USA 95:9448-9453, 1998 Mohle R., Bautz F., Rafii S., and Lothar K.:Regulation of transendothelial migration of hematopoietic progenitor cells. Annu NY Aca.of Science. 872: 176- 186, 1999 Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanghan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegui, E., and Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis (2001) Nature 410, 50-56 Murakami, T., Maki, W., Cardones, A. R., Fang, H., Tun Kyi, A., Nestle, F. O., and Hwang, S. T. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res, 62: 7328-7334, 2002. Nagasawa T., Hirota S., Tachibana K., and Kishimoto T.:Defects of B-cell lymphopoiesis and bone marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382, August 15: 635-638, 1996 Nagasawa T., Nakajima T., Tachibaba K., Iizasa H., Bleul C. C., Yoshie O., Matsushima K., Yoshida N., Springer T. A., Kishimoto T. Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc. Natl. Acad. Sci. USA, 93: 14726-14729, 1996. Okabe S., Fukuda S., Broxmeyer H.E.:Activation of Wiskott- Aldrich syndrome protein and its association with other proteins by stromal cell- derived factor-1α is associated with cell migration in a T-lymphocyte line. Exper. Hemat. 30: 761-766, 2002 Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002; 2: 657-672. Palanki MS. Inhibitors of AP-1 and NF-kappa B mediated transcriptional activation: therapeutic potential in autoimmune diseases and structural diversity. Curr. Med. Chem. 2002; 9:219-27. Pan MR, Hung WC. Nonsteroidal anti-inflammatory drugs inhibit matrixl metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription. J. Biol. Chem. 2002; 277:32775-80. Park BK, Zeng X, Glazer RI. Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. Cancer Res. 2001; 61:7647-53. Parks WC, and Mecham RP. Matrix metalloproteinases.1998 Academic Press. San Diego. Peled A., Grabovsky V., Habler L., Sandbank J., Arenzana-Seisdedos F., Petir I., Ben-Hur H., Lapidot T.:The chemokine SDF-1 stimulates integrin- mediated attest of CD34+ cells on vascular endothelium under shear flow. J Clin. Invest. 104:1199-1211, 1999 Philip S, Bulbule A, Kundu GC. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B- mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J. Biol. Chem. 2001; 276:44926-35. Phillips R., Ager A.:Activation of pertussis toxin-sensitive CXCL12 (SDF- 1) receptors mediates transendothelial migration of T lymphocytes across lymph node high endothelial cells. Eur. J. Immun.32: 837-847,2002 Qin Yu, and Ivan Stamenkovic. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 2000 Jan 15; 14 (2): 163-76. Rezaie P., Trillo-Pzaos G., Everall LP., Male D.K.:Expression of β- chemokines and chemokine receptors in human fetal astrocytr and microglial co- culture: potential role of chemokines in the developing CNS. Glia 37:64-76, 2002 Rosenberg GA. Matrix metalloproteinases in neuroinflammation. GLIA. 2002; 39: 279-291. Rossi, D. and Zlotnik, A. The biology of chemokines and their receptors. Annu Rev Immunol, 18: 217-242, 2000. Schols D., Struyf S., Van Damme J., Este J. E., Henson G., De Clercq E. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J. Exp. Med., 186: 1383-1388, 1997. Sehgal, A., Ricks, S., Boynton, A. L., Warrick, J., and Murphy, G. P. Molecular characterization of CXCR-4: a potential brain tumor-associated gene. J. Surg. Oncol., 69: 239-248, 1998. Sternlicht MD and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001; 17: 463-516. Taichman, R. S., Cooper, C., Keller, E. T., Pienta, K. J., Taichman, N. S., and McCauley, L. K. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res, 62: 1832-1837, 2002. Ticchioni M., Charvet C., Noraz N., Lamy L., Steinberg M., Bernard A., Deckert M.:Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration. Blood, 99, No.9, May 1:3111-3118, 2002 Wang J.F., Park I-W., Groopman J.E.:Stromal cell-derived factor-1αstimulate tyrosine phosphorylation of mutiple focal adhesion protein and induces migration of hematopoietic progenitor cells: roles of phosphoinositide- 3 kinase and protein kinase C. Blood 95, No.8, April 15:2502-2513, 2000 Wang X, Mori T, Jung JC, Fini ME, Lo EH. Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortica cultures and involvement of MAP kinase. J. Neurotrauma. 2002; 19:615-25. Webb CP, Taylor GA, Jeffers M, Fiscella M, Oskarsson M, Resau JH, Vande Woude GF. Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasis. Oncogene 1998: 17: 2019-2025. Welch DR, Sakamaki T, Pioquinto R, Leonard TO, Goldberg SF, Hon Q, Erikson RL, Rieber M, Rieber MS, Hicks DJ, Bonventre JV, Alessandrini A. Transfection of constitutively active mitogen-activated protein/extracellular signal- regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells. Cancer Res. 2000; 60:1552-6. Wells T.N.,Power C.A., Lusti-Narasimhan M., Hoogewerf A.J., Cooke R.M., Chung C.W., Peotsh M.C, Proudfoot A.E.:Selectivity and antagonist, of chemokine receptors. J. Leuk. Biol.,59:53-60, 1996 Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999; 13:781-92. Xia, M., Leppert, D., Hauser, S. L., Sreedharan, S. P., Nelson, P. J., Krensky, A. M., and Goetzl, E. J. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane (1996) J. Immunol. 156, 160-167 Yoshida M, Korfhagen TR, Whitsett JA. Surfactant protein D regulates NF- kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J. Immunol. 2001; 166:7514-9. Zhang X-F., Wang J-F., Matczak E., Proper J., Groopman J.E:Janus kinase 2 is involved in stromal cell- derived factor-1α- induced tyrosine phosphorylation of focal adhesion proteins and migration. Blood, 100, No.8 October 15:3342-3348, 2001 Zhang Y, Thant AA, Machida K, Ichigotani Y, Naito Y, Hiraiwa Y, Senga T, Sohara Y, Matsuda S, Hamaguchi M. Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90. CancerRes. 2002; 62: 3962-3965. Zhou, Y., Larsen, P. H., Hao, C., and Yong, V. W. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem, 277: 49481-49487, 2002.
|